Invention Grant
- Patent Title: Inhibitors of plasma kallikrein
- Patent Title (中): 血浆激肽释放酶抑制剂
-
Application No.: US13154410Application Date: 2011-06-06
-
Publication No.: US08258170B2Publication Date: 2012-09-04
- Inventor: Sukanto Sinha , Tamie Jo Chilcote
- Applicant: Sukanto Sinha , Tamie Jo Chilcote
- Applicant Address: US CA San Francisco
- Assignee: Activesite Pharmaceuticals, Inc.
- Current Assignee: Activesite Pharmaceuticals, Inc.
- Current Assignee Address: US CA San Francisco
- Agency: Kilpatrick, Townsend & Stockton LLP
- Main IPC: A61K31/415
- IPC: A61K31/415 ; C07D231/14
Abstract:
The present invention provides compounds that inhibit the activity of plasma kallikrein (PK) and methods of preventing and treating the formation of thrombin during or after a PK dependent disease or condition, for example, after fibrinolysis treatment.
Public/Granted literature
- US20110301215A1 INHIBITORS OF PLASMA KALLIKREIN Public/Granted day:2011-12-08
Information query
